Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print May 11, 2007
DOI: 10.2337/db06-0825

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db06-0825v1
56/8/2116    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, C.-Q.
Right arrow Articles by Clare-Salzler, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, C.-Q.
Right arrow Articles by Clare-Salzler, M. J
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Transfusion of Apoptotic ß Cells Induces Immune Tolerance to ß Cell Antigens and Prevents Type 1 Diabetes in NOD Mice

Chang-Qing Xia1, Ruihua Peng1, Yushi Qiu1, Mani Annamalai1, David Gordon1, and Michael J Clare-Salzler1

1Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL32610, USA

Correspondence: xia{at}pathology.ufl.edu

Correspondence: salzler{at}pathology.ufl.edu

OBJECTIVE:In vivo induction of ß cell apoptosis has been demonstrated to be effective in preventing type 1 diabetes (T1D) in NOD mice. Based upon the notion that steady-state cell apoptosis is associated with self-tolerance, and the need for developing a more practical approach using apoptotic ß cells to prevent T1D, the current study is designed to investigate apoptotic ß cells induced ex vivo in preventing T1D.

RESEARCH DESIGN AND METHODS:NIT-1 cell line serves as a source of ß cells. Apoptotic NIT-1 cells are prepared by ultraviolet B (UVB) irradiation. Three weekly transfusions of UVB-NIT-1 (1x 105/mouse) or PBS are employed to determine whether transfusions of UVB-NIT-1 induce immune tolerance to ß cell antigens in vivo, and prevent T1D. The suppression of anti-ß cell antibodies, polarization of Th cells and induction of regulatory T cells by UVB-NIT-1 treatment are investigated.

RESULTS:The transfusions of apoptotic NIT-1 cells suppress anti-ß cell antibody development, and induce Th2 responses and IL-10-producing Tr1 cells. Importantly, this treatment significantly delays and prevents the onset of diabetes when 10-week old NOD mice are treated. Adoptive transfer of splenocytes from UVB-NIT-1-treated mice prevents diabetes caused by simultaneously injected diabetogenic splenocytes in NOD-Rag-/- mice. Moreover, the proliferation of adoptively transferred CFSE-labeled ß-cell antigen-specific TCR-transgenic T cells in UVB-NIT-1-treated mice is markedly suppressed.

CONCLUSIONS:The transfusion of apoptotic ß cells effectively protects T1D in NOD mice by inducing immune tolerance to ß cell antigens. This approach has a great potential for immune intervention of human T1D.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.